Aldis Puķītis

1.8k total citations
27 papers, 538 citations indexed

About

Aldis Puķītis is a scholar working on Surgery, Genetics and Epidemiology. According to data from OpenAlex, Aldis Puķītis has authored 27 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 8 papers in Genetics and 7 papers in Epidemiology. Recurrent topics in Aldis Puķītis's work include Inflammatory Bowel Disease (6 papers), Pancreatitis Pathology and Treatment (5 papers) and Biosimilars and Bioanalytical Methods (5 papers). Aldis Puķītis is often cited by papers focused on Inflammatory Bowel Disease (6 papers), Pancreatitis Pathology and Treatment (5 papers) and Biosimilars and Bioanalytical Methods (5 papers). Aldis Puķītis collaborates with scholars based in Latvia, Germany and Denmark. Aldis Puķītis's co-authors include Vladimir Lyadov, Romanas Zykus, Richard Charnley, Sébastien Gaujoux, Fatih Saygılı, Adi Lahat, Stefan Schreiber, Byong Duk Ye, Shomron Ben‐Horin and Walter Reinisch and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Aldis Puķītis

26 papers receiving 532 citations

Peers

Aldis Puķītis

GENET

SURGE

EPIDE

PHYSI

ONCOL

Igor Jovanović Serbia

Andrew Y. F. Li Yim Netherlands

Rocío Puig Spain

Nick Topley United Kingdom

Khaled Dajani Canada

Jane Keidan United Kingdom

Valentí Puig‐Diví Spain

Valentina Rampulla Italy

Tianpei Wang China

Babak Movahedi United States

Igor Jovanović Serbia

Aldis Puķītis

267 ×1.3

GENET

90 ×0.5

SURGE

277 ×1.7

EPIDE

36 ×0.2

PHYSI

37 ×0.3

ONCOL

Citations per year, relative to Aldis Puķītis Aldis Puķītis (= 1×) peers Igor Jovanović

Countries citing papers authored by Aldis Puķītis

Since Specialization

Citations

This map shows the geographic impact of Aldis Puķītis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aldis Puķītis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aldis Puķītis more than expected).

Fields of papers citing papers by Aldis Puķītis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aldis Puķītis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aldis Puķītis. The network helps show where Aldis Puķītis may publish in the future.

Co-authorship network of co-authors of Aldis Puķītis

This figure shows the co-authorship network connecting the top 25 collaborators of Aldis Puķītis. A scholar is included among the top collaborators of Aldis Puķītis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aldis Puķītis. Aldis Puķītis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Puķītis, Aldis, et al.. (2025). Thromboelastography-guided assessment of coagulation in decompensated liver cirrhosis for the evaluation of blood component transfusions. Clinical and Experimental Hepatology. 11(2). 147–151.

Pečulis, Raitis, Ilona Mandrika, Jurijs Nazarovs, et al.. (2024). Tumor and α‐ SMA ‐expressing stromal cells in pancreatic neuroendocrine tumors have a distinct RNA profile depending on tumor grade. Molecular Oncology. 19(3). 659–681. 2 indexed citations

Puķītis, Aldis, et al.. (2023). Neuroendocrine Carcinoma of the Extrahepatic Bile Ducts: A Case Report. American Journal of Case Reports. 24. e939239–e939239. 1 indexed citations

Schreiber, Stefan, Shomron Ben‐Horin, Jarosław Leszczyszyn, et al.. (2021). Randomized Controlled Trial: Subcutaneous vs Intravenous Infliximab CT-P13 Maintenance in Inflammatory Bowel Disease. Gastroenterology. 160(7). 2340–2353. 141 indexed citations

Olesen, Søren Schou, Jakob Lykke Poulsen, Srdan Novovic, et al.. (2020). Multiple risk factors for diabetes mellitus in patients with chronic pancreatitis: A multicentre study of 1117 cases. United European Gastroenterology Journal. 8(4). 453–461. 27 indexed citations

Tjora, Erling, Georg Dimcevski, Stephan Haas, et al.. (2020). Patient reported exposure to smoking and alcohol abuse are associated with pain and other complications in patients with chronic pancreatitis. Pancreatology. 20(5). 844–851. 13 indexed citations

Meija, Laila, et al.. (2020). The role of body muscle mass as an indicator of activity in inflammatory bowel disease patients. Clinical Nutrition ESPEN. 40. 193–200. 9 indexed citations

Ben‐Horin, Shomron, Jarosław Leszczyszyn, Adi Lahat, et al.. (2020). OP24 A novel subcutaneous infliximab (CT-P13): 1-year results including switching results from intravenous infliximab (CT-P13) in patients with active Crohn’s disease and ulcerative colitis. Journal of Crohn s and Colitis. 14(Supplement_1). S021–S022. 10 indexed citations

Sokolovska, Jeļizaveta, et al.. (2020). Thiopurine S-methyltransferase genetic polymorphisms in adult patients with inflammatory bowel diseases in the Latvian population. Therapeutic Advances in Gastroenterology. 13. 3974126290–3974126290. 2 indexed citations

10.

Puķītis, Aldis, et al.. (2019). Stauffer’s Syndrome in Patient with Metastatic Prostate Cancer. SHILAP Revista de lepidopterología. 2019. 1–3. 9 indexed citations

11.

Frøkjær, Jens Brøndum, Esben Bolvig Mark, Povilas Ignatavičius, et al.. (2019). A Clinical Feasible Method for Computed Tomography-Based Assessment of Sarcopenia in Patients With Chronic Pancreatitis. Pancreas. 48(10). 1354–1359. 14 indexed citations

12.

Ye, Byong Duk, Byung Ik Jang, Adi Lahat, et al.. (2019). Tu1715 – A Novel Formulation of Ct-P13 (Infliximab Biosimilar) for Subcutaneous Administration: 1-Year Result from a Phase I Open-Label Randomized Controlled Trial in Patients with Active Crohn's Disease. Gastroenterology. 156(6). S–1096. 4 indexed citations

13.

Mark, Esben Bolvig, Vladimir Lyadov, Søren Schou Olesen, et al.. (2018). Reliability and validity of the new VikingSlice software for computed tomography body composition analysis. European Journal of Clinical Nutrition. 73(1). 54–61. 22 indexed citations

14.

Schreiber, Stefan, Byung Ik Jang, Adi Lahat, et al.. (2018). Tu2018 - Novel Formulation of CT-P13 (Infliximab Biosimilar) for Subcutaneous Administration: Initial Results from a Phase I Open-Label Randomized Controlled Trial in Patients with Active Crohn's Disease. Gastroenterology. 154(6). S–1371. 12 indexed citations

15.

Čerņevskis, Harijs, et al.. (2016). Mckittrick-Wheelock Syndrome: A Case Report. 2(1). 1 indexed citations

16.

Pokrotnieks, Juris, et al.. (2014). Current opinion on the management of iron deficiency anaemia in gastrointestinal diseases.. PubMed. 97–105. 3 indexed citations

17.

Zykus, Romanas, Fatih Saygılı, Aldis Puķītis, et al.. (2014). Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: A systematic review. Pancreatology. 15(1). 19–24. 131 indexed citations

18.

Puķītis, Aldis, et al.. (2013). P474 Infliximab induction therapy on AA amyloidosis associated with Crohn's disease: case report. Journal of Crohn s and Colitis. 7. S199–S199. 1 indexed citations

19.

Puķītis, Aldis, et al.. (2013). Effect of infliximab induction therapy on secondary systemic amyloidosis associated with Crohn's disease: case report and review of the literature.. PubMed. 22(3). 333–6. 13 indexed citations

20.

Dignaß, Axel, Anders Eriksson, Anders Kilander, et al.. (2010). Clinical trial: five or ten cycles of granulocyte–monocyte apheresis show equivalent efficacy and safety in ulcerative colitis. Alimentary Pharmacology & Therapeutics. 31(12). 1286–1295. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact